TRANSLATIONAL POTENTIAL OF CHOLESTEROL SUPPLEMENTATION-BASED STRATEGIES FOR HUNTINGTON'S DISEASE

被引：1
|
作者：
Valenza, Marta [1 ]
Birolini, Giulia [1 ]
Di Paolo, Eleonora [1 ]
Vezzoli, Elena [1 ]
Maniezzi, Claudia [2 ]
Talpo, Francesca [2 ]
Biella, Gerardo [2 ]
Ruozi, Barbara [3 ]
Tosi, Giovanni [3 ]
Cattaneo, Elena [1 ]
机构：
[1] Univ Milan, Dept Biosci, Milan, Italy
[2] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy
[3] Univ Modena & Reggio Emilia, Dept Life Sci, Nanomed & Pharmaceut Technol, Modena, Italy
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2018年 / 89卷
关键词：
D O I：
10.1136/jnnp-2018-EHDN.250
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
I14
引用
收藏
页码：A93 / A93
页数：1
相关论文
共 50 条
  • [41] Huntington's disease: Pathological mechanisms and therapeutic strategies
    Ramaswamy, Shilpa
    Shannon, Kathleen M.
    Kordower, Jeffrey H.
    CELL TRANSPLANTATION, 2007, 16 (03) : 301 - 312
  • [42] Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
    Jimenez-Sanchez, Maria
    Licitra, Floriana
    Underwood, Benjamin R.
    Rubinsztein, David C.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (07): : 1 - 22
  • [43] THE DEVELOPMENT OF TRANSLATIONAL BIOMARKERS OF NEUROINFLAMMATION IN A MOUSE MODEL OF HUNTINGTON'S DISEASE
    Riggall, Laura
    Siow, Bernard
    Golay, Xavier
    Bates, Gillian
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A11 - A11
  • [44] Cholesterol biosynthesis is impaired in Huntington's disease patients: implication for brain cholesterol homeostasis
    Leoni, V.
    Mariotti, C.
    Valenza, M.
    Cattaneo, E.
    Di Donato, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 166 - 166
  • [45] Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease
    Corey-Bloom, Jody
    Jia, Haiqun
    Aikin, Alaina M.
    Thomas, Elizabeth A.
    JOURNAL OF HUNTINGTONS DISEASE, 2014, 3 (03) : 311 - 316
  • [46] Creatine supplementation lowers brain glutamate levels in Huntington’s disease
    Andreas Bender*
    Dorothee P. Auer*
    Thomas Merl
    Ralf Reilmann
    Phillip Saemann
    Alexander Yassouridis
    Julia Bender
    Adolf Weindl
    Matthias Dose
    Thomas Gasser
    Thomas Klopstock
    Journal of Neurology, 2005, 252 (1) : 36 - 41
  • [47] Creatine supplementation lowers brain glutamate levels in Huntington's disease
    Bender, A
    Auer, DP
    Merl, T
    Reilmann, R
    Saemann, P
    Yassouridis, A
    Bender, J
    Weindl, A
    Dose, M
    Gasser, T
    Klopstock, T
    JOURNAL OF NEUROLOGY, 2005, 252 (01) : 36 - 41
  • [48] Potential neuroprotective effects of pridopidine in Huntington's disease
    DiPardo, A.
    Maglione, V.
    Favellato, M. G.
    Amico, E.
    Squitieri, F.
    MOVEMENT DISORDERS, 2013, 28 : S272 - S273
  • [49] POTENTIAL NEUROPROTECTIVE EFFECTS OF PRIDOPIDINE IN HUNTINGTON'S DISEASE
    Di Pardo, A.
    Alberti, S.
    Maglione, V.
    Amico, E.
    Squitieri, F.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A57 - A57
  • [50] Connection between astrocytes, cholesterol and synaptic disfunction in Huntington's disease
    Valenza, M.
    GLIA, 2017, 65 : E32 - E32
12345